At the phenotypic level, for example, discrepancies between the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status of the primary tumor and its respective metastases are frequently observed3. This evidence concerns the gene ERBB2 and neoplasm.